fungizone
Fungizone (Amphotericin B) is a lipid-based polyene antifungal used to treat Aspergillosis, Blastomycosis, Chronic Mucocutaneous Candidiasis, Cutaneous Candidiasis.
Amphotericin B · by Apothecon
Available as a generic: Amphotericin B
Key facts
- Active ingredient
- Amphotericin B
- Drug class
- Lipid-Based Polyene Antifungal
- Form
- Topical, Suspension, Injectable
- Strength
- Amphotericin B 3%
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Apothecon
- FDA application
- NDA050313
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
Dosage forms
Topical, Suspension and Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Fungizone treat?
- Fungizone (Amphotericin B) may be used to treat aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, cutaneous candidiasis, coccidioidomycosis, cystitis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Fungizone?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Fungizone. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Fungizone?
- Fungizone is marketed by Apothecon. You can see Apothecon's full profile, rating, and other products on pharmaranks.
- Is Fungizone a brand-name or generic drug?
- Fungizone is a brand-name product with the active ingredient Amphotericin B. Lower-cost generic equivalents containing Amphotericin B are available — ask your pharmacist.
- Is Fungizone available over the counter?
- No. Fungizone is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Fungizone come in?
- Fungizone is currently marketed as topical, suspension and injectable, per the FDA's National Drug Code Directory.
- What class of drug is Fungizone?
- Fungizone is classified as lipid-based polyene antifungal, polyene antifungal, per the FDA's Established Pharmacologic Class.
- Is Fungizone FDA-registered?
- Fungizone is on record with the U.S. FDA under application number NDA050313. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about AMPHOTERICIN B
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 15,853 reports naming AMPHOTERICIN B — the active ingredient in Fungizone, and the FDA flagged 96% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- pyrexia850 reports
- multiple organ dysfunction syndrome606 reports
- acute kidney injury577 reports
- sepsis519 reports
- febrile neutropenia507 reports
- respiratory failure487 reports
- septic shock478 reports
- pneumonia472 reports
Read these as a signal, not a rate. A report does not mean AMPHOTERICIN B caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Fungizone head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
fungizone
New